CClinicalTrials.gg
Active, not recruitingNCT05618678DIGNITYUpdated Feb 20, 2024

Pilot Testing Decision Making in Aging and Dementia for Autonomy Program in Nursing Homes

An interventional study of DIGNITY and Infection Control in Dementia, Staff Attitude and Nurse's Role, sponsored by Penn State University. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-02-20.

Sponsored by Penn State University · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Primary completion was expected by May 2024, 2 years 5 months ago, but the record still lists the study as active, not recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
4
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to adapt, pilot test, and evaluate the feasibility, acceptability, and preliminary effectiveness of DIGNITY (Decision-making In aGing and demeNtIa for auTonomY) for Preference-Based Care in Nursing Homes as a new evidence-based intervention to support nursing home staff to safely honor care and activity preferences of residents' living with dementia in rural, typically under resourced nursing home communities.

Read the detailed description

Of 6.5 million older Americans are living with Alzheimer's disease and related forms of dementia (ADRD), two thirds will die in a nursing home (NH) where staff are not prepared to deliver a minimal level of federally mandated care. Care in NHs is delivered by an ever-changing workforce of 1.3 million staff members who are responsible to provide person-centered care (PCC)- that is care based on knowing and honoring residents preferences for care and activities of daily living. NH residents have reported they are not satisfied with efforts to honor their preferences for everyday living and care activities. For residents living with ADRD this can lead to a loss of dignity, anger, agitation, isolation, depression, and negative social interactions between residents ultimately reducing quality of life. A prominent, known barrier to honoring residents' preferences is the predominantly risk adverse attitudes and behaviors of NH staff. DIGNITY (Decision-making in aging and dementia for autonomy) is novel multi-level intervention based in theory and evidence aimed at empowering nursing home staff to negotiate residents' risky preferences by addressing intrinsic and system barriers to safely honoring a resident's preferences with decision aids, care planning, and staff coaching/education. In the proposed project, we will implement DIGNITY in a pilot cluster randomized trial of 120 nursing home staff and residents across four rural nursing homes located in Pennsylvania. Our aims are to: 1.) To explore stakeholder perspectives on the relevance and feasibility of implementing the DIGNITY intervention in rural, underserved nursing home communities; and 2.) examine the feasibility, acceptability, and preliminary effectiveness of DIGNITY within four rural, underserved nursing homes. Outcomes will be evaluated at baseline and 12 weeks following baseline education on the DIGNITY protocol. This study is a critical next step in developing evidence-based interventions that target gaps in direct-care workforce skills needed to enhance quality of care delivery to persons with ADRD living in NHs.

02

Conditions studied

  • Dementia
  • Staff Attitude
  • Nurse's Role
  • Nursing Homes

Browse trials for

Keywords

  • Shared Decision Making
  • Person-Centered Care
03

In context

Dementia

2,172 studies on the registry are indexed under Dementia; 540 are open to participants now.

This study's planned enrollment of 4 is below the median of 83 across 1,629 interventional studies indexed under Dementia.

Browse Dementia studies →

Lead sponsor

Penn State University is the lead sponsor of 263 studies on the registry; 51 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 10 (77%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria for Nursing Homes:

  1. Located in rural Pennsylvania as defined by the Center for Rural Pennsylvania
  2. Administrator articulates commitment to delivering person-centered care
  3. NH has a dedicated dementia care unit and/or a total bed capacity of 50 beds or more
  4. NH has the capacity to participate in the study activities for the term of the study as determined by nursing home leadership
  5. NH has a dedicated quality improvement/safety team that meets regularly
  6. NH has a stable internet connectivity for program delivery

Exclusion Criteria:

  • Nursing Home does not meet inclusion criteria.

Convenience sampling will be used to recruit nursing home staff and residents within nursing homes.

Inclusion criteria for Nursing Home Staff:

  1. 18 years or older
  2. Employed by the participating nursing home for at least 6 months
  3. Fluent in written and spoken English
  4. Provides and/or influences direct care delivery to older adults with dementia

Inclusion criteria for Residents:

  1. Resides in nursing home study site for at least 3 months
  2. English speaking
  3. Documented diagnosis of Alzheimer's disease or related dementia (ADRD)
  4. Have a stated preference that nursing home staff indicated poses a risk to their health and/or safety
  5. Provides consent/assent to be enrolled
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
4 participants (estimated)

Study arms

  • Active comparator
    Infection Control Training

    Nursing homes randomized to this arm of the study receive CDC guidelines and evidence based information on infection prevention prevention and control. Nursing home staff implement these standard in everyday resident care. Additionally, nursing home staff are invited to participate in Extension for Community Healthcare Outcomes (ECHO) sessions via real-time interactive videoconferencing software to support the implementation of the CDC guidelines and evidence-based practices.

    Behavioral: Infection Control

  • Experimental
    DIGNITY Intervention

    Nursing homes randomized to this arm of the study receive an evidence based risk assessment and care planning protocol for supporting decision making and aging in dementia for autonomy (DIGNITY). Nursing home staff use this manual to implement risk assessment and care planning for resident preferences that they perceive to carry a risk to the resident's health and/or safety. In addition nursing home staff participate in Extension for Community Healthcare Outcomes (ECHO) sessions via real-time interactive videoconferencing software to support the implementation of the DIGNITY protocol.

    Behavioral: DIGNITY

Interventions

  • BehavioralDIGNITY

    DIGNITY is a multi-component, multi-level intervention that guides shared decision-making in nursing homes to support person-centered dementia care. Based in theory, this intervention targets nursing home staff attitudes and behaviors around assessing and judging whether to engage in risk situations to support resident preferences for everyday living and care despite cognitive decline due to dementia. It includes a protocol manual, baseline training on how to implement the DIGNITY strategy, and six ECHO sessions to help frontline staff negotiate intrinsic and cultural factors in preference situations that carry a risk to residents' health and safety.

  • BehavioralInfection Control

    This is an attention control intervention with similar dose of educational content and attention from interventionist. It includes distribution of links to the CDC Infection Control Practice Guidelines for nursing homes, a baseline training on infection control practices for frontline workers, and six ECHO coaching sessions.

06

What researchers measure

Primary outcomes

  1. Intervention Feasibility

    Evidence of Feasibility (Feasibility of Intervention Measure)

    Time frame: 12 weeks after baseline education on DIGNITY protocol

  2. Staff Behavioral Intent

    Evidence of Staff Intent to Honor Resident's Preference (Investigator developed survey item)

    Time frame: 12 weeks after baseline education on DIGNITY protocol

  3. Resident Satisfaction

    Evidence of resident satisfaction with preference (Preferences for Everyday Living Inventory)

    Time frame: 12 weeks after baseline education on DIGNITY protocol

  4. Intervention Fidelity

    Evidence of staff fidelity to the DIGNTY Intervention (Investigator developed DIGNITY Intervention Fidelity Assessment Checklist)

    Time frame: 12 weeks after baseline education on DIGNITY protocol

Secondary outcomes

  1. Staff Self - Efficacy

    Changes in perceived self-efficacy in Person-Centered Risk Management (Investigator Developed Self Efficacy Survey for Person-Centered Risk Management)

    Time frame: 12 weeks after baseline education on DIGNITY protocol

  2. Intervention Acceptability

    Staff rate intervention acceptability on the Acceptability of Intervention Measure

    Time frame: 12 Weeks after baseline education on DIGNITY protocol

07

Study locations

1 site
  • Pennsylvania State University
    State College, Pennsylvania 16803, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05618678
Lead sponsor
Penn State University
Responsible party
Liza Behrens, PhD, RN (Assistant Professor, Penn State University) — Principal investigator
First posted
Nov 16, 2022
Start date
Jan 24, 2023
Primary completion
May 2024 (estimated)
Completion
May 2024 (estimated)
Last update
Feb 20, 2024

Study contacts

Liza Behrens, PhD
principal investigator · Penn State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion